Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pharmaron Beijing Co Ltd

3759
Current price
13.94 HKD 0 HKD (0.00%)
Last closed 14.34 HKD
ISIN CNE100003PG4
Sector Healthcare
Industry Biotechnology
Exchange Hong Kong Stock Exchange
Capitalization 53 951 958 367 HKD
Yield for 12 month -34.25 %
1Y
3Y
5Y
10Y
15Y
3759
21.11.2021 - 28.11.2021

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vitro biology, DMPK, in vivo pharmacology, and compound management services; chemistry, manufacturing, and controls services. It also provides clinical development services, including integrated radio labelled science, clinical development, and clinical trial recruitment services; safety assessment, integrated drug discovery, and bioanalysis services; and biologics and cell and gene therapy services, comprising biologics laboratory, biologics CDMO, cell and gene therapy laboratory, and gene therapy CDMO services. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China. Address: Building 1, Beijing, China, 100176

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

132.9 HKD

P/E ratio

13.8783

Dividend Yield

1.57 %

Current Year

+12 456 536 912 HKD

Last Year

+11 083 588 013 HKD

Current Quarter

+3 167 276 455 HKD

Last Quarter

+2 883 358 570 HKD

Current Year

+4 452 834 728 HKD

Last Year

+4 068 400 363 HKD

Current Quarter

+1 078 562 390 HKD

Last Quarter

+941 580 768 HKD

Key Figures 3759

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 2 390 873 556 HKD
Operating Margin TTM 16.79 %
PE Ratio 13.8783
Return On Assets TTM 4.15 %
PEG Ratio
Return On Equity TTM 13.58 %
Wall Street Target Price 132.9 HKD
Revenue TTM 11 810 206 901 HKD
Book Value 7.58 HKD
Revenue Per Share TTM
Dividend Share 0.2 HKD
Quarterly Revenue Growth YOY 10 %
Dividend Yield 1.57 %
Gross Profit TTM 2 679 520 413 HKD
Earnings per share 1.11 HKD
Diluted Eps TTM 1.11 HKD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -12.2 %
Profit Margin 15.97 %

Dividend Analytics 3759

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

23 %

Dividend History 3759

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.22
Ex Dividend Date 27.06.2024
Forward Annual Dividend Yield 1.37 %
Last Split Factor 15:10
Payout Ratio 19.78 %
Last Split Date 18.07.2023
Dividend Date

Stock Valuation 3759

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 13.8783
Forward PE
Enterprise Value Revenue 4.5023
Price Sales TTM 4.5682
Enterprise Value EBITDA 22.3099
Price Book MRQ 1.9795

Financials 3759

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 3759

For 52 weeks

7.99 HKD 24.88 HKD
50 Day MA 13.25 HKD
Shares Short Prior Month
200 Day MA 10.6 HKD
Short Ratio
Shares Short
Short Percent